In line with the priorities outlined by the Head of State at the “Central Asia – China” Summit, the year 2026 has been officially declared the Year of Science and Education in Kazakhstan. This decision reflects the country’s strategic course toward strengthening scientific potential, supporting researchers, and expanding international scientific cooperation.

Against this backdrop, a joint meeting of the Scientific and Technical Council of the Ministry of Health of the Republic of Kazakhstan and the Department of Life and Health Sciences of the National Academy of Sciences under the President of the Republic of Kazakhstan was held at the National Center for Biotechnology. The goal of the meeting was to define strategic priorities for scientific and technical policy in the field of healthcare and to outline promising directions for the development of medical science.

The meeting was attended by the Minister of Health of the Republic of Kazakhstan, Akmaral Alnazarova; academicians of the National Academy of Sciences of Kazakhstan Vyacheslav Lokshin, Serik Akshulakov, and Yuri Pya; as well as leading scientists, rectors of medical universities, and representatives of scientific and professional organizations.

Minister Alnazarova emphasized that the development of national science, the strengthening of its competitiveness, support for young specialists, and the commercialization of research are key priorities of state policy. She noted that the importance of scientific advances in the medical field is steadily growing, and that the projects presented at the meeting should serve as examples and benchmarks for the entire healthcare system.

Key topics of discussion included:

• Approval of the updated composition of the Scientific and Technical Council;
• Defining priorities in biotechnology and medical research;
• Enhancing the link between fundamental and applied science;
• Transferring high-tech developments into clinical practice.

Academician Vyacheslav Lokshin highlighted the need to strengthen the connection between basic research and clinical solutions, emphasizing that fundamental science provides the foundation for long-term innovation in medicine.

Academician Serik Akshulakov shared his experience in implementing an original spinal surgery method that minimizes muscle tissue trauma and accelerates patient recovery.
Meanwhile, Anаr Turmukhambetova, Rector of Astana Medical University, presented the results of a foresight study extending to 2030, outlining key trends in medicine and biotechnology.

Participants presented several innovative projects, including:

• Personalized spinal implants developed using 3D printing technologies (National Center for Neurosurgery);
• The ALEM project, a strategic initiative for the sustainable development of the healthcare system (University Medical Center);
• 3D cellular models and organoids as the basis for personalized therapy (National Center for Biotechnology);
• Application of genomic technologies in diagnostics and treatment (Nazarbayev University).

Based on the outcomes of the meeting, recommendations were developed to enhance scientific management, facilitate knowledge transfer, strengthen the integration of science and clinical practice, and support human capital development for scientific initiatives.

As a key player in the biomedical research ecosystem and a structure uniting leading scientific organizations, the QazBioPharm National Holding fully supports the state policy aimed at strengthening Kazakhstan’s scientific potential. The Holding will continue to play an active role in advancing biomedical research, implementing cutting-edge developments, and elevating the international standing of Kazakhstan’s scientific community.